What Researchers Did
Researchers investigated the effect of the perfluorocarbon emulsion Oxycyte on platelet count and function in a swine model of decompression sickness, comparing it to saline treatment and sham controls.
What They Found
The study found no significant changes in normalized platelet counts. However, prothrombin time was elevated in the Oxycyte-treated decompression sickness group from 48 to 192 hours compared to saline-treated controls, and activated partial thromboplastin time was also elevated from 168 to 192 hours compared to sham controls. Despite these changes, no bleeding events were observed.
What This Means for Canadian Patients
This animal study suggests that while a perfluorocarbon emulsion like Oxycyte may not affect platelet numbers in decompression sickness, it could alter coagulation parameters. For Canadian patients, this means that if such a non-recompressive therapy were to be considered, careful monitoring of clotting factors would be essential, despite the absence of observed bleeding.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or participants.
Study Limitations
A primary limitation of this study is its use of a swine model, which may not fully translate to human physiology and clinical outcomes.